Delivery Order SPE2DB22D2218-SPE2DB26FR1QE
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Nucynta 50 mg tablets (100 count) with a contract ceiling value of $1,225.04. This firm fixed price delivery order is scheduled for completion by September 22, 2025, and represents a competitive award with no set-aside designation. The order will be fulfilled from the contractor's location in Conshohocken, Pennsylvania, where the company maintains its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Nucynta 75 mg tablets (100 count) on September 25, 2025, with a contract ceiling value of $4,482.56. This delivery order represents a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 26, 2025. The work will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Nucynta 100 mg tablets (100 count) with a ceiling value of $2,251.73. This firm fixed-price delivery order, with an ultimate completion date of August 21, 2025, represents a competitively awarded non-set-aside contract. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Nucynta 50 mg tablets (100 units) with a ceiling value of $1,225.04. This competitively awarded, firm fixed-price delivery order is not subject to any set-aside designation and is scheduled for completion by September 5, 2025. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Nucynta 50 mg tablets (100 count) with a ceiling value of $1,225.04. This firm fixed-price delivery order, with an ultimate completion date of July 23, 2025, represents a direct fulfillment of pharmaceutical needs through the federal medical supply chain. The contract is not set-aside and was competitively awarded, reflecting AmerisourceBergen's established capability as a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Nucynta ER 100 mg tablets (60-count units) with a ceiling value of $1,472.04. This is a firm fixed price delivery order with no set-aside designation, reflecting a competitively awarded contract. The order is scheduled for ultimate completion on September 24, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 100 tablets of Nucynta 50 mg, a pharmaceutical pain management product, with a contract value of $4,001.46. This non-competitive delivery order, issued on August 12, 2025, utilizes firm fixed pricing and is set to conclude on August 13, 2025. The work will be performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order represents a single...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on October 7, 2025, for the supply of Nucynta Tabs 50mg, a pain management pharmaceutical. This firm fixed-price delivery order, valued at $4,442.48, is scheduled for completion by October 8, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. The award was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's proven...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Nucynta 75 mg tablets (100 count) with a ceiling value of $2,451.24. This is a firm fixed-price delivery order with an ultimate completion date of August 22, 2025, and represents a non-set-aside competitive award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 16, 2025, for the supply of Nucynta 100 mg tablets (100-count units) under a firm fixed-price contract valued at $1,908.20. This is a non-set-aside competitive award issued as a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (contract number SPE2DX), valued at $999.99 billion and extending through December 2026. The...
- SPE2DB22D2218Indefinite Delivery Contract
- SPE2DB22D2218-SPE2DB26FR1QEDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 28, 2025, for the supply of Nucynta 50 mg tablets (100-count units) with a contract ceiling value of $6,903.24. The award is structured as a firm fixed-price delivery order with an ultimate completion date of October 29, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This is a competitively awarded, non-set-aside contract, reflecting AmerisourceBergen Drug Corp's demonstrated capability to meet federal pharmaceutical procurement requirements through open competition. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply medications and medical commodities to support military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, holds a critical position in the federal medical supply chain, serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through this flexible contracting vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.9k | 10/28/25 |